Ai Virtual Agent Selection, Implementation and Support Keys to Success
Improving Population Health via Non-traditional Partnerships
Efficient Data Management in the Healthcare Space
Transform Healthcare with a Passion for Innovation
Significant technological change often means a cultural shift for...
NovletMattis, Chief Information Officer, Orlando Health
Disrupting the CIO Comfort Zone to Innovate and Transform How...
Wes Williams, VP & CIO, Mental Health Center Of Denver
Bringing the Worlds of Technology and Health Closer to Each Other
Kristin Myers, Chief Information Officer, Mount Sinai Health System
The Biopsychosocial Model: The Future of Remote Patient Monitoring
Heather Comerci Reyes, Md, Me; Michael Hasselberg, Phd, Chief Digital Health Officer, University Of Rochester Medical Center
Thank you for Subscribing to CIO Applications Weekly Brief

How to Improve Infectious Diseases with Nanotechnology

The advent and advancement of nanotechnology in medicine can create a more straightforward treatment regimen with lower dose frequency and much less maintenance.
Fremont, CA: Nanomedicine employs nanoscale technology for medical applications, which may include the use of particles ranging in size from 1 to 100 nm. In recent years, the novel use of nanotechnology in medicine has become an exciting development, with innovative Food and Drug Administration (FDA)-approved concepts that can revolutionize disease detection and treatment.
Infections are a significant burden throughout the world, with high mortality rates associated with conditions such as lower respiratory infections, tuberculosis, diarrhea, malaria, HIV, and others. These infectious diseases have a greater impact in the developing world, where mortality rates associated with these conditions are the highest because of a scarcity of vaccines and anti-infectives.
Observations from temporal trends in mortality show that, while overall mortality rates are decreasing, there is still a large disparity in death rates between high and low socio-demographic index (SDI) countries. Furthermore, clinical trials for contagious diseases are lower than trials for other disorders such as cardiovascular disease and even cancer, demonstrating the need for advanced infectious disease treatment through nanotechnology.
Nanotechnology in Medicine
The advent and advancement of nanotechnology in medicine can create a more straightforward treatment regimen with lower dose frequency and much less maintenance.
The use of injectable nanocarriers capable of transporting, delivering, or releasing drugs over long periods of time would be revolutionary for the challenges that low SDI countries face. Nanocarriers, which control drug release by utilizing an inactive vehicle such as a lipid or polymer, or a slow breakdown of a drug-using poorly soluble mediums such as nano-drug crystals, are examples of drug delivery systems.
Low SID Challenges
Low socio-demographic index countries frequently face a slew of challenges. This includes patients who do not adhere to therapies, the need for ongoing patient monitoring, and other factors such as the inability to pay for drugs or maintaining drug stability in high or humid temperatures.
These factors can make it difficult for low-income countries to effectively treat patients with infections, ranging from hospitals being unable to adequately support their patients to patients being unable to access drugs.
Long-term care for conditions such as HIV, tuberculosis, or malaria can significantly burden patients and healthcare systems. HIV would necessitate lifelong treatment, whereas tuberculosis would necessitate a combination of oral medications administered over several months to years. Prolonged treatment plans can lead to a lack of patient adherence, reducing treatment efficacy and resulting in failure because of a lack of optimal drug levels.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
Featured Vendors
-
Jason Vogel, Senior Director of Product Strategy & Development, Silver Wealth Technologies
James Brown, CEO, Smart Communications
Deepak Dube, Founder and CEO, Datanomers
Tory Hazard, CEO, Institutional Cash Distributors
Jean Jacques Borno, CFP®, Founder & CEO, 1787fp
-
Andrew Rudd, CEO, Advisor Software
Douglas Jones, Vice President Operations, NETSOL Technologies
Matt McCormick, CEO, AddOn Networks
Jeff Peters, President, and Co-Founder, Focalized Networks
Tom Jordan, VP, Financial Software Solutions, Digital Check Corp
Tracey Dunlap, Chief Experience Officer, Zenmonics